MENU
DH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

DH stock forecast, quote, news & analysis

Definitive Healthcare Corp is a provider of healthcare commercial intelligence... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
DH
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for DH with price predictions
Oct 21, 2026

Momentum Indicator for DH turns positive, indicating new upward trend

DH saw its Momentum Indicator move above the 0 level on October 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In 68 of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for DH just turned positive on October 19, 2026. Looking at past instances where DH's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.

Following a +4.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where DH advanced for three days, in 192 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

The Aroon Indicator entered an Uptrend today. In 123 of 164 cases where DH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 54 cases where DH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

DH broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.797) is normal, around the industry mean (4.100). P/E Ratio (-0.667) is within average values for comparable stocks, (13.263). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (0.437) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. DH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 3.19B. The market cap for tickers in the group ranges from 708 to 51.9B. VEEV holds the highest valuation in this group at 51.9B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 16%. PHR experienced the highest price growth at 15%, while DRIO experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -5%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 52
Price Growth Rating: 53
SMR Rating: 86
Profit Risk Rating: 97
Seasonality Score: 7 (-100 ... +100)
Momentum Indicator for DH turns positive, indicating new upward trend